Charles Bovaird

Charles Bovaird

Charles Bovaird is a Financial Writer and Consultant with strong knowledge of securities markets and investing concepts. Having accumulated more than six years' worth of experience, he has done work for financial institutions including Moody's Analytics and Citizens Commercial Banking. 

An author of 500+ publications, his work has appeared in publications including New York Post, Washington Post, Boston Herald, Chicago Tribune and Fortune. Mr. Bovaird created all the industrial finance training for a company with 300+ people and has given speeches on financial literacy for Mensa and Boston Rotaract.

  • Showing 1-15 of 152 items
  • 1
  • 2
  • 3
  • ...
  • 11
  • >>
  1. Stocks

    3 Big Cap Winners: How Revenues Are Fueling These Stocks

    Investors might find gains in large cap stocks with strong fundamentals.
  2. Stocks

    Why the S&P May Outperform in 2017 Amid Turmoil

    The S&P 500 index could push higher this year.
  3. Stocks

    Gundlach Sees Big Market Drop, Says Raise Cash

    Stock speculators should raise cash, says Jeffrey Gundlach.
  4. Stocks

    Apple and Pfizer's Tax Windfall (AAPL, PFE, MSFT)

    Apple and Pfizer could enjoy multi-billion dollar one-time tax windfalls.
  5. Stocks

    Six Trends That Could Hammer the Markets (SPX, DJIA)

    Stocks face six major threats.
  6. Stocks

    S&P Will Jump 11%, Then Face a Bleak 2018, MS Says (SPX)

    How much higher can stocks climb?
  7. Stocks

    How Trump's Travel Ban Could Cost U.S. $18 Billion (DAL, AAL)

    Trump's travel ban could cost U.S. tourism $18 billion.
  8. Stocks

    Where the Bulls Run Fastest: Emerging Stock Markets (BABA, UGP)

    Emerging-market stocks are producing strong returns.
  9. Stocks

    Dividend Gusher: Energy Companies Boost Payouts (CVX, OXY, XOM)

    Oil companies have boosted dividend payouts lately.
  10. Stocks

    Stocks Could Rise 50%, Says Yale's Shiller

    Robert Shiller, a nobel-winning economist, has predicted that the bull market could last several years.
  11. Stocks

    These Big Drug Stocks May Cure the Trump Blues (MRK, LLY)

    Certain pharma stocks have significant upside potential.
  12. Stocks

    Stocks Touted as Trump Winners Look Like Losers (X, CXW)

    Stocks that rallied following Trump's election have suffered lately.
  13. Stocks

    Short Sellers Profit Big Off Intel, Nordstrom, Priceline (INTC, JWN)

    Short sellers generated strong returns by shorting stocks May 8 – 12.
  14. Stocks

    Why Stocks Could Fall 20%: A Technical View

    Stocks could fall up to 20%, says prominent technical analyst.
  15. Stocks

    Why White House Crises Don't Kill Bull Markets (SPX, DJIA)

    Stocks are trading near record levels in spite of political turmoil.
  • Showing 1-15 of 152 items
  • 1
  • 2
  • 3
  • ...
  • 11
  • >>